First-year follow-up costs of myocardial infarction management in Poland from the payer’s perspective
Anna Skowrońska(University of Cambridge), Piotr Jankowski(Postgraduate School of Molecular Medicine), Marcin Grabowski, Ryszard Gellert, Bartosz Szafran, Paweł Teisseyre(Warsaw University of Technology), Mariusz Gąsior(Silesian Center for Heart Disease), Jarosław Pinkas(Postgraduate School of Molecular Medicine), Jacek Kubica(Nicolaus Copernicus University), Maciej Lesiak, Jarosław D. Kasprzak(Medical University of Lodz), Agnieszka Doryńska(Institute of Cardiology), Radosław Sierpiński(Cardinal Stefan Wyszynski University in Warsaw), Siamala Sinnadurai(Medical University of Białystok), Patrycja Gryka, Karol Kamiński(Medical University of Białystok), Magdalena Dzierwa, Mariusz Wójcik(University of Rzeszów)
Cited by 2
Related Papers
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
|Journal of Clinical Oncology|2014|2.8k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
|European Heart Journal|2023|1.4k
EAE/ASE Recommendations for Image Acquisition and Display Using Three-Dimensional Echocardiography
|Journal of the American Society of Echocardiography|2011|1.1k
EAE/ASE Recommendations for Image Acquisition and Display Using Three-Dimensional Echocardiography
|European Heart Journal - Cardiovascular Imaging|2012|591